tradingkey.logo
tradingkey.logo
Buscar

ICAD Inc

ICAD
Añadir a la lista de seguimiento
3.870USD
0.0000.00%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
105.19MCap. mercado
PérdidaP/E TTM

Más Datos de ICAD Inc Compañía

iCAD, Inc. provides artificial intelligence-powered cancer detection. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging and computed tomography. ProFound Suite offers 360-degree solutions for cancer detection, density assessment, and personalized risk evaluation, all based on a 2D or 3D mammogram’s collection of images. ProFound Density Assessment standardizes and simplifies breast density reporting, algorithmically examining a woman’s breast anatomy from the mammogram image.

Información de ICAD Inc

Símbolo de cotizaciónICAD
Nombre de la empresaICAD Inc
Fecha de salida a bolsaDec 13, 1984
Director ejecutivoMs. Dana R. Brown
Número de empleados66
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 13
Dirección98 Spit Brook Rd Ste 100
CiudadNASHUA
Bolsa de valoresEuronext Paris
PaísUnited States of America
Código postal03062-5737
Teléfono16038825200
Sitio Webhttps://www.icadmed.com/
Símbolo de cotizaciónICAD
Fecha de salida a bolsaDec 13, 1984
Director ejecutivoMs. Dana R. Brown

Ejecutivos de ICAD Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Eric Lonnqvist
Mr. Eric Lonnqvist
Chief Financial Officer
Chief Financial Officer
1.40K
-6.16%
Ms. Dana R. Brown
Ms. Dana R. Brown
Executive Chairman of the Board, President, Chief Executive Officer
Executive Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Michael John Doyle
Mr. Michael John Doyle
Independent Director
Independent Director
--
-100.00%
Mr. Andrew H. (Andy) Sassine
Mr. Andrew H. (Andy) Sassine
Independent Director
Independent Director
--
--
Dr. Rakesh Patel, M.D.
Dr. Rakesh Patel, M.D.
Independent Director
Independent Director
--
-100.00%
Mr. Mark Koeniguer
Mr. Mark Koeniguer
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Jonathan Go
Mr. Jonathan Go
Chief Technology Officer
Chief Technology Officer
--
-100.00%
Dr. Hedvig Hricak, M.D., Ph.D.
Dr. Hedvig Hricak, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Susan Alyson Wood, Ph.D.
Dr. Susan Alyson Wood, Ph.D.
Independent Director
Independent Director
--
-100.00%
John Nesbett
John Nesbett
Investor Relations
Investor Relations
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Eric Lonnqvist
Mr. Eric Lonnqvist
Chief Financial Officer
Chief Financial Officer
1.40K
-6.16%
Ms. Dana R. Brown
Ms. Dana R. Brown
Executive Chairman of the Board, President, Chief Executive Officer
Executive Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Michael John Doyle
Mr. Michael John Doyle
Independent Director
Independent Director
--
-100.00%
Mr. Andrew H. (Andy) Sassine
Mr. Andrew H. (Andy) Sassine
Independent Director
Independent Director
--
--
Dr. Rakesh Patel, M.D.
Dr. Rakesh Patel, M.D.
Independent Director
Independent Director
--
-100.00%
Mr. Mark Koeniguer
Mr. Mark Koeniguer
Chief Commercial Officer
Chief Commercial Officer
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de ICAD Inc?

Los cinco principales accionistas de ICAD Inc son: Mr. Eric Lonnqvist

¿Cuántas instituciones poseen acciones de ICAD Inc (ICAD)?

A fecha de 2025Q2, 117 instituciones poseen acciones de ICAD Inc, con un valor de mercado combinado de aproximadamente 9.75M, lo que representa el 35.51% del total de acciones. En comparación con el 2025Q1, el accionariado institucional ha aumentado en 1190732.00.

¿Cuál es la mayor fuente de ganancias de ICAD Inc?

El 2025Q2, el segmento empresarial Subscription term licenses generó la ganancia más alta para ICAD Inc, ascendiendo a 1.78M y representando el 36.62% de la ganancia total.